Fig. 7From: The relevance of the non-invasive biomarkers lncRNA GAS5/miR-21 ceRNA regulatory network in the early identification of diabetes and diabetic nephropathy(A, B) Diagnostic signatures using logistic regression models of the diabetic group (DM + DN) and normal controls (N). (C, D) Diagnostic signatures using logistic regression models of DN and non-nephrotic group (DM + N). DN + DM: the diabetic group includes patients with diabetes mellitus and diabetic nephropathy; N + DM: non-nephrotic group includes the normal control group and patients with solely diabetes mellitusBack to article page